The role of peroxiredoxin III on late stage of proerythrocyte differentiation

Biochemical and Biophysical Research Communications

Volumn 359, Issue 4, 2007, Pages 1030-1036

  Yang, Hee Young ^a,b   Jeong, Dong Kee ^c   Kim, Seok Ho ^a,b   Chung, Kyoung Jin ^a   Cho, Eun Jin ^a,b   Yang, Ung ^b   Lee, Sang Ryeul ^b   Lee, Tae Hoon ^b  

^a Chonnam National University   (South Korea)

^b Dental Science Research Institute   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

Erythroid differentiation; Hematopoietic progenitor cells; Peroxiredoxin III

Indexed keywords

BETA GLOBIN; CYTARABINE; PEROXIREDOXIN; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CD34 SELECTION; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INHIBITION; ERYTHROPOIESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINE; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; PEROXIDASES;

ARA; MURINAE;

EID: 34250620940     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.007     Document Type: Article

References (28)

1. Chae H.Z., Kim H.J., Kang S.W., and Rhee S.G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45 (1999) 101-112
2. Rhee S.G., Kang S.W., Chang T.S., Jeong T.S., and Kim W.K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
3. Araki M., Nanri H., Ejima K., Murasato Y., Fujiwara T., Nakashima Y., and Ikeda M. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J. Biol. Chem. 274 (1999) 2271-2278
4. Chang T.S., Cho C.S., Park S., Yu S., Kang S.W., and Rhee S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 279 (2004) 41975-41984
5. Wonsey D.R., Zeller K.I., and Dang C.V. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc. Natl. Acad. Sci. USA 99 (2002) 6649-6654
6. Nemoto Y., Yamamoto T., Takada S., Matsui Y., and Obinata M. Antisense RNA of the latent period gene (MER5) inhibits the differentiation of murine erythroleukemia cells. Gene 91 (1990) 261-265
7. Yamamoto T., Matsui Y., Natori S., and Obinata M. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80 (1989) 337-343
8. Vizirianakis I.S., and Tsiftsoglou A.S. Induction of murine erythroleukemia cell differentiation is associated with methylation and differential stability of poly(A)+ RNA transcripts. Biochim. Biophys. Acta 1312 (1996) 8-20
9. Tsiftsoglou A.S., Pappas I.S., and Vizirianakis I.S. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol. Therapeut. 100 (2003) 257-290
10. Luisi-DeLuca C., Mitchell T., Spriggs D., and Kufe D.W. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine. J. Clin. Invest. 73 (1984) 821-827
11. Eisbruch A., Blick M., Evinger-hodges M.J., Beran M., Andersson B., Gutterman J.U., and Kurzrock R. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line. Cancer 62 (1988) 1171-1178
12. + cells. Biochem. Biophy. Res. Commun. 353 (2007) 978-984
13. Rabilloud T., Berthier R., Vincon M., Ferbus D., Goubin G., and Lawrence J.J. Early events in erythroid differentiation: accumulation of the acidic peroxidoxin (PRP/TSA/NKEF-B). Biochem. J. 312 (1995) 699-705
14. Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J. Biol. Chem. 280 (2005) 18120-18129
15. Kawano T., Horiguchi-Yamada J., Saito S., Iwase S., Furukawa Y., Kano Y., and Yamada H. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells. Leuk. Res. 28 (2004) 623-629
16. Cantor A.B., and Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21 (2001) 3368-3376
17. Furukawa Y., Kikuchi J., Nakamura M., Iwase S., Yamada H., and Matsuda M. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation. Br. J. Haematol. 110 (2000) 663-673
18. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11 (1997) 118-124
19. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
20. Forman H.J., Fukuto J.M., and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. 287 (2004) C246-C256
21. Shivdasani R.A., and Orkin S.H. The transcriptional control of hematopoiesis. Blood 87 (1996) 4025-4039
22. Rodriguez P., Bonte E., Krijgsveld J., Kolodziej K.E., Guyot B., Heck A.J.R., Vyas P., deBoer E., Grosveld F., and Strouboulis J. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 24 (2005) 2354-2366
23. Tanak M., Zheng J., Kitajima K., Kita K., Yoshikawa H., and Nakano T. Differentiation status dependent function of FOG-1. Genes Cells 9 (2004) 1213-1226
24. Deconinck A.E., Mead P.E., Tevosian S.G., Crispino J.D., Katz S.G., Zon L.I., and Orkin S.H. FOG acts as a repressor of red blood cell development in Xenopus. Development 127 (2000) 2031-2040
25. Letting D.L., Chen Y.Y., Rokowski C., Reedy S., and Blobel G.A. Context-dependent regulation of GATA-1 by friend of GATA-1. Proc. Natl. Acad. Sci. USA 101 (2004) 476-481
26. Cuddihy A.E., Brents L.A., Aziz N., Bender T.P., and Kuehl W.M. Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 13 (1993) 3505-3513
27. Bartunek P., Kralova J., Blendinger G., Dvorak M., and Zenke M. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 22 (2003) 1927-1937
28. Hoffman B., Amanullah A., Shafarenko M., and Liebermann D.A. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21 (2002) 3414-3421